Difference in the Care of Patients with Amyotrophic Lateral Sclerosis With and Without Intervention from the Palliative Care Team: Observations from a Center in Japan

被引:2
作者
Takahashi, Kazuya [1 ,2 ]
Murakami, Fumi [2 ,3 ]
Komai, Kiyonobu [1 ]
Ishida, Chiho [1 ]
Kato-Motozaki, Yuko [1 ,2 ]
机构
[1] Natl Hosp Org Iou Natl Hosp, Hokuriku Brain & Neuromuscular Dis Ctr, Dept Neurol, Ni73-1 Iwade Machi, Kanazawa, Ishikawa 9200192, Japan
[2] Natl Hosp Org Iou Natl Hosp, Hokuriku Brain & Neuromuscular Dis Ctr, Palliat Care Team, Kanazawa, Ishikawa, Japan
[3] Natl Hosp Org Iou Natl Hosp, Hokuriku Brain & Neuromuscular Dis Ctr, Nursing Unit, Kanazawa, Ishikawa, Japan
来源
PALLIATIVE MEDICINE REPORTS | 2021年 / 2卷 / 01期
关键词
amyotrophic lateral sclerosis; opioid; palliative care; MULTIDISCIPLINARY ALS;
D O I
10.1089/pmr.2020.0084
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Despite the significant palliative care needs for people living with amyotrophic lateral sclerosis (ALS), palliative medicine in Japan is mainly focused on oncologic disease. Objective: To compare the care provided to patients with ALS with and without intervention from the palliative care team (PCT and non-PCT groups, respectively). Design: This is a retrospective case-control study. Setting: One ALS center in Japan. Participants: Sixty patients with clinically definite ALS treated until death from January 2012 to December 2019. Measurements: We compared the two groups based on the presence of advance directives, patient age, use of noninvasive and invasive ventilation, maximum opioid dosage, and use of nonopioid palliative medications such as antidepressants and anxiolytics. We also compared the prescribing practices of the attending physicians. Results: There was no difference in the rate of advance directive completion between the PCT and non-PCT groups. Although all but one patient in the PCT group used opioids, only half of the patients in the non-PCT group used opioids (p < 0.001). The mean maximum opioid dosage was higher in the PCT group than in the non-PCT group (p = 0.003). Moreover, 79.2% and 41.7% of the PCT and non-PCT groups, respectively, received antidepressants or antianxiety agents (p = 0.004). Maximum opioid dosages were not different on the basis of attending physician's experience level. Conclusions: Opioid and nonopioid medications intended for symptom management were more likely to be prescribed to patients with ALS who received intervention from a PCT.
引用
收藏
页码:201 / 206
页数:6
相关论文
共 13 条
  • [1] Integration of a palliative care specialist in an amyotrophic lateral sclerosis clinic: Observations from one center
    Brizzi, Kate
    Paganoni, Sabrina
    Zehm, April
    De March, Fabiola
    Berry, James D.
    [J]. MUSCLE & NERVE, 2019, 60 (02) : 137 - 140
  • [2] ALS patients on TPPV - Totally locked-in state, neurologic findings and ethical implications
    Hayashi, H
    Oppenheimer, EA
    [J]. NEUROLOGY, 2003, 61 (01) : 135 - 137
  • [3] Japanese Society for Palliative Medicine:, PALL CAR TEAM REG RE PALL CAR TEAM REG RE
  • [4] Japanese Society for Palliative Medicine:, 2019, PALL CAR TEAM REG RE PALL CAR TEAM REG RE
  • [5] Kawata Akihiro, 2008, Rinsho Shinkeigaku, V48, P476
  • [6] Patients who survive 5 years or more with ALS in Olmsted County, 1925-2004
    Mateen, Farrah J.
    Carone, Marco
    Sorenson, Eric J.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (10) : 1144 - 1146
  • [7] Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology
    Miller, R. G.
    Jackson, C. E.
    Kasarskis, E. J.
    England, J. D.
    Forshew, D.
    Johnston, W.
    Kalra, S.
    Katz, J. S.
    Mitsumoto, H.
    Rosenfeld, J.
    Shoesmith, C.
    Strong, M. J.
    Woolley, S. C.
    [J]. NEUROLOGY, 2009, 73 (15) : 1218 - 1226
  • [8] Ogino Mieko, 2008, Rinsho Shinkeigaku, V48, P973
  • [9] Ogino Mieko, 2010, Rinsho Shinkeigaku, V50, P1026
  • [10] Societas Neurologica Laponica, 2013, PRACTICE GUIDELINES